发明授权
- 专利标题: COMPOSITION FOR TREATING DENTIN HYPERSENSITIVITY
- 专利标题(中): 组成为Hyper牙本质敏感性的治疗
-
申请号: EP00951699.8申请日: 2000-08-04
-
公开(公告)号: EP1202705B1公开(公告)日: 2007-12-05
- 发明人: DODD, Gregory, P. , HALECKY, Alan, A. , MARKOWITZ, Kenneth, J.
- 申请人: BLOCK DRUG COMPANY, INC.
- 申请人地址: CSC The United States Corporation 830 Bear Tavern Road West Trenton, New Jersey 08628 US
- 专利权人: BLOCK DRUG COMPANY, INC.
- 当前专利权人: BLOCK DRUG COMPANY, INC.
- 当前专利权人地址: CSC The United States Corporation 830 Bear Tavern Road West Trenton, New Jersey 08628 US
- 代理机构: Reeves, Julie Frances
- 优先权: US147438P 19990805; US419514 19991018
- 国际公布: WO2001010392 20010215
- 主分类号: A61K8/25
- IPC分类号: A61K8/25 ; A61K6/033 ; A61L27/00 ; A61Q11/00
摘要:
A composition for restoring defects in calcified tissues comprises an amorphous bioactive particulate consisting essentially of calcium, silicon and oxygen. Said agent may be selected from the group consisting of : a) a reaction product of an organic silicate source and a source of calcium; b) a calcium containing hydrolysis product of tetraethylorthosilicate; c) a calcium containing silica sol-gel; d) a binary calcium oxide and silicate precipitated material; e) a synthetic analog of a naturally occurring wollastonite-like calcium silicate; and f) a precipitated reaction product of soluble calcium source and a silicate solution. A process for producing the amorphous bioactive particulate consists essentially of adding a sufficient amount of a solution of a soluble calcium source to a solution of a silicate or silicate precursor to cause a precipitation of calcium-containing silicate particulate.
公开/授权文献
- EP1202705A2 COMPOSITION FOR RESTORING DEFECTS IN CALCIFIED TISSUES 公开/授权日:2002-05-08
信息查询